RIPK1 activation has been shown to promote hepatic steatosis and hepatic inflammation in a conventional high-fat diet (HFD)-induced NAFLD model17,18. This evidence concerns the gene RIPK1 and metabolic dysfunction-associated steatotic liver disease.